:::

Yusuf Emre Gürel (TR)

06.04.2018

10:20 - 10:30

Applying PCSK9 Inhibitors to Optimize Outcomes in Patients With Dyslipidemia: Current Guidelines Recommendations Yusuf Emre Gürel (TR)

PCSK9 Inhibitors: A New Horizon in LDL-C Management